financetom
Business
financetom
/
Business
/
McDonald's to Close All Standalone CosMc's Locations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
McDonald's to Close All Standalone CosMc's Locations
May 26, 2025 1:34 PM

02:43 PM EDT, 05/23/2025 (MT Newswires) -- McDonald's (MCD) said Friday that it will close all standalone pilot CosMc's locations on a rolling basis, starting late June.

The company will also discontinue the CosMc's app and said the main goal of beverage test concept was to create a launchpad for learning.

"Building on the insights gained from the pilot standalone locations, CosMc's-inspired flavors will be landing at McDonald's as part of the upcoming US beverage test, the company said.

Price: 315.35, Change: +1.04, Percent Change: +0.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RTX's Raytheon Unit Wins Semiconductor Development Contract From DARPA
RTX's Raytheon Unit Wins Semiconductor Development Contract From DARPA
Oct 2, 2024
09:56 AM EDT, 10/02/2024 (MT Newswires) -- RTX's (RTX) Raytheon unit said Wednesday that it won a three-year, two-phase contract from the US Department of Defense's Defense Advanced Research Projects Agency, or DARPA, to develop foundational ultra-wide bandgap semiconductors. No financial terms were disclosed. The company said contract work will be carried out at its foundry in Andover, Massachusetts, with...
Johnson & Johnson Says Study Shows Erleada Provides 'Significant' Prostate Cancer Survival Over Enzalutamide
Johnson & Johnson Says Study Shows Erleada Provides 'Significant' Prostate Cancer Survival Over Enzalutamide
Oct 2, 2024
09:57 AM EDT, 10/02/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday results from a study showed its Erleada, or apalutamide, provided a 'statistically significant overall survival benefit' at 24 months compared with enzalutamide in patients with metastatic castration-sensitive prostate cancer. Johnson & Johnson ( JNJ ) said the head-to-head study of apalutamide and enzalutamide included nearly...
Novo Nordisk has mitigation plans to minimize disruption from port strikes
Novo Nordisk has mitigation plans to minimize disruption from port strikes
Oct 2, 2024
(Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has mitigation plans in place to minimize or prevent any disruption to its production due to sea port strikes in the United States. The maker of popular drugs, Wegovy and Ozempic, plans to ship its products to and from the U.S. via air freight, a company spokesperson said. The company imports...
--Corning Keeps Quarterly Dividend at $0.28 Per Share; Payable Dec. 13 to Shareholders of Record on Nov. 15
--Corning Keeps Quarterly Dividend at $0.28 Per Share; Payable Dec. 13 to Shareholders of Record on Nov. 15
Oct 2, 2024
09:59 AM EDT, 10/02/2024 (MT Newswires) -- Price: 44.80, Change: +0.26, Percent Change: +0.57 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved